MetasThera
Kraków, PL · 1 known investors
metasThera develops drugs targeting metastatic cancer cells by focusing on the cancer-specific plasma membrane citrate transporter pmCiC, which plays a role in cancer metabolism and adaptation.
BiotechHealthtechMedical Devices